States that do provide coverage have tried to manage costs by putting prescribing limits on the GLP-1s. There’s also some ...

The decision counters a proposal by the Biden Administration to reimburse beneficiaries for the weight-loss medications.

The telehealth-consultation platform said it plans to continue expanding its weight loss offerings.

Hims & Hers Health shares jumped Tuesday as the company added Eli Lilly’s weight-loss drug Zepbound and diabetes treatment ...

Zepbound, Mounjaro and liraglutide are part of the class of weight loss medications called GLP-1s ... can traditionally only ...

To what extent will health clinics go to keep selling in-demand weight-loss drugs now that the FDA has outlawed cheaper ...

CMS ends Biden-era proposal to expand Medicare coverage of anti-obesity drugs. Seniors continue paying out of pocket for ...

The telehealth company Hims & Hers Health is expanding its weight-loss offerings by adding new medications to its platform.

red down pointing triangle said it is expanding its weight-loss offerings with the addition of Eli Lilly LLY-3.56%decrease; red down pointing triangle & Co. Zepbound and generic liraglutide.

Meanwhile, the first major obesity-related phase 3 trial for orforglipron is set to complete in July. If the data from the ...